vimarsana.com

Card image cap

This randomized clinical trial assesses the efficacy and safety of a repeated low-level red-light intervention in preventing incident myopia among children in C

Related Keywords

Helsinki , Eteläuomen Läi , Finland , Melbourne , Victoria , Australia , Shanghai , China , Hongqiao , Sichuan , Taiwan , Guangzhou , Guangdong , Mingguang , Jiangsu , Chinese , Xun Xu , Iolmaster Carl Zeiss Meditec , Xieyi Weishikang , Eyerising Ltd , National Key Rd Program Of China , Treatment Center , International Myopia Institute , Technology Commission , Outstanding Academic Technical Leaders Program , Eyerising International Pty Ltd , Suzhou Xuanjia Optoelectronics Technology , Hospital Ethics Committee , Department Of Clinical Research , China National Medical Products Administration , Institute Inc , Technology Commission Clinical Research , R Group For Statistical Computing , Centre For Eye Research Australia , Innovation Research Project Of Shanghai Science , National Natural Science Foundation Of China , Southeast Asia , Shanghai General Hospital Ethics Committee , Consolidated Standards , Reporting Trials , Statistical Computing , China National Medical Products , Compliance Monitoring , Early Treatment Diabetic Retinopathy Study , Guangzhou Xieyi Weishikang , Carl Zeiss Meditec , Subgroup Analyses , Myopia Incidence , Myopic Shift , Clinical Research , Shanghai Eye Disease Prevention , Shanghai Eye Hospital , Shanghai Vision Health Center , Shanghai Children Myopia Institute , Eye Research Australia , Royal Victorian Eye , Ear Hospital , Interest Disclosures , Drs Zhu , Eyerising International Pty , National Key Rd Program , National Natural Science Foundation , Technology Innovation Action , Technical Leaders Program , Medical Innovation Research Project , Shanghai Science ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.